Copyright Reports & Markets. All rights reserved.

Global Oxaliplatin Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Oxaliplatin by Type
    • 1.3.1 Overview: Global Oxaliplatin Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Oxaliplatin Consumption Value Market Share by Type in 2024
    • 1.3.3 Mannitol
    • 1.3.4 Glucose Solution
    • 1.3.5 Lactose Solution
    • 1.3.6 Others
  • 1.4 Global Oxaliplatin Market by Application
    • 1.4.1 Overview: Global Oxaliplatin Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Colorectal Cancer
    • 1.4.3 Stomach Cancer
    • 1.4.4 Ovarian Cancer
    • 1.4.5 Others
  • 1.5 Global Oxaliplatin Market Size & Forecast
  • 1.6 Global Oxaliplatin Market Size and Forecast by Region
    • 1.6.1 Global Oxaliplatin Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Oxaliplatin Market Size by Region, (2020-2031)
    • 1.6.3 North America Oxaliplatin Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Oxaliplatin Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Oxaliplatin Market Size and Prospect (2020-2031)
    • 1.6.6 South America Oxaliplatin Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Oxaliplatin Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Sanofi-Aventis
    • 2.1.1 Sanofi-Aventis Details
    • 2.1.2 Sanofi-Aventis Major Business
    • 2.1.3 Sanofi-Aventis Oxaliplatin Product and Solutions
    • 2.1.4 Sanofi-Aventis Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Sanofi-Aventis Recent Developments and Future Plans
  • 2.2 Yakult honsha
    • 2.2.1 Yakult honsha Details
    • 2.2.2 Yakult honsha Major Business
    • 2.2.3 Yakult honsha Oxaliplatin Product and Solutions
    • 2.2.4 Yakult honsha Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Yakult honsha Recent Developments and Future Plans
  • 2.3 Dr Reddy's laboratories
    • 2.3.1 Dr Reddy's laboratories Details
    • 2.3.2 Dr Reddy's laboratories Major Business
    • 2.3.3 Dr Reddy's laboratories Oxaliplatin Product and Solutions
    • 2.3.4 Dr Reddy's laboratories Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Dr Reddy's laboratories Recent Developments and Future Plans
  • 2.4 Sun Pharmaceutical
    • 2.4.1 Sun Pharmaceutical Details
    • 2.4.2 Sun Pharmaceutical Major Business
    • 2.4.3 Sun Pharmaceutical Oxaliplatin Product and Solutions
    • 2.4.4 Sun Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sun Pharmaceutical Recent Developments and Future Plans
  • 2.5 Teva
    • 2.5.1 Teva Details
    • 2.5.2 Teva Major Business
    • 2.5.3 Teva Oxaliplatin Product and Solutions
    • 2.5.4 Teva Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Teva Recent Developments and Future Plans
  • 2.6 Fresenius Kabi
    • 2.6.1 Fresenius Kabi Details
    • 2.6.2 Fresenius Kabi Major Business
    • 2.6.3 Fresenius Kabi Oxaliplatin Product and Solutions
    • 2.6.4 Fresenius Kabi Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Fresenius Kabi Recent Developments and Future Plans
  • 2.7 Hospira
    • 2.7.1 Hospira Details
    • 2.7.2 Hospira Major Business
    • 2.7.3 Hospira Oxaliplatin Product and Solutions
    • 2.7.4 Hospira Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Hospira Recent Developments and Future Plans
  • 2.8 Mylan
    • 2.8.1 Mylan Details
    • 2.8.2 Mylan Major Business
    • 2.8.3 Mylan Oxaliplatin Product and Solutions
    • 2.8.4 Mylan Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Mylan Recent Developments and Future Plans
  • 2.9 Jiangsu Hengrui Medicine
    • 2.9.1 Jiangsu Hengrui Medicine Details
    • 2.9.2 Jiangsu Hengrui Medicine Major Business
    • 2.9.3 Jiangsu Hengrui Medicine Oxaliplatin Product and Solutions
    • 2.9.4 Jiangsu Hengrui Medicine Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Jiangsu Hengrui Medicine Recent Developments and Future Plans
  • 2.10 Nanjing Pharmaceutical Factory
    • 2.10.1 Nanjing Pharmaceutical Factory Details
    • 2.10.2 Nanjing Pharmaceutical Factory Major Business
    • 2.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Product and Solutions
    • 2.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Nanjing Pharmaceutical Factory Recent Developments and Future Plans
  • 2.11 Jiangsu Aosaikang Pharmaceutical
    • 2.11.1 Jiangsu Aosaikang Pharmaceutical Details
    • 2.11.2 Jiangsu Aosaikang Pharmaceutical Major Business
    • 2.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product and Solutions
    • 2.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments and Future Plans
  • 2.12 Qilu Pharmaceutical
    • 2.12.1 Qilu Pharmaceutical Details
    • 2.12.2 Qilu Pharmaceutical Major Business
    • 2.12.3 Qilu Pharmaceutical Oxaliplatin Product and Solutions
    • 2.12.4 Qilu Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Qilu Pharmaceutical Recent Developments and Future Plans
  • 2.13 Hisun Pharmaceutical
    • 2.13.1 Hisun Pharmaceutical Details
    • 2.13.2 Hisun Pharmaceutical Major Business
    • 2.13.3 Hisun Pharmaceutical Oxaliplatin Product and Solutions
    • 2.13.4 Hisun Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Hisun Pharmaceutical Recent Developments and Future Plans
  • 2.14 Lunan Pharmaceutical
    • 2.14.1 Lunan Pharmaceutical Details
    • 2.14.2 Lunan Pharmaceutical Major Business
    • 2.14.3 Lunan Pharmaceutical Oxaliplatin Product and Solutions
    • 2.14.4 Lunan Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Lunan Pharmaceutical Recent Developments and Future Plans
  • 2.15 Luoxin
    • 2.15.1 Luoxin Details
    • 2.15.2 Luoxin Major Business
    • 2.15.3 Luoxin Oxaliplatin Product and Solutions
    • 2.15.4 Luoxin Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Luoxin Recent Developments and Future Plans
  • 2.16 Halfsky Pharmacy
    • 2.16.1 Halfsky Pharmacy Details
    • 2.16.2 Halfsky Pharmacy Major Business
    • 2.16.3 Halfsky Pharmacy Oxaliplatin Product and Solutions
    • 2.16.4 Halfsky Pharmacy Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Halfsky Pharmacy Recent Developments and Future Plans
  • 2.17 YRPG
    • 2.17.1 YRPG Details
    • 2.17.2 YRPG Major Business
    • 2.17.3 YRPG Oxaliplatin Product and Solutions
    • 2.17.4 YRPG Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 YRPG Recent Developments and Future Plans
  • 2.18 Hainan Jinrui Pharmaceutical
    • 2.18.1 Hainan Jinrui Pharmaceutical Details
    • 2.18.2 Hainan Jinrui Pharmaceutical Major Business
    • 2.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Product and Solutions
    • 2.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Hainan Jinrui Pharmaceutical Recent Developments and Future Plans
  • 2.19 Jari Pharmaceutical
    • 2.19.1 Jari Pharmaceutical Details
    • 2.19.2 Jari Pharmaceutical Major Business
    • 2.19.3 Jari Pharmaceutical Oxaliplatin Product and Solutions
    • 2.19.4 Jari Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Jari Pharmaceutical Recent Developments and Future Plans
  • 2.20 Chiatai Tianqing
    • 2.20.1 Chiatai Tianqing Details
    • 2.20.2 Chiatai Tianqing Major Business
    • 2.20.3 Chiatai Tianqing Oxaliplatin Product and Solutions
    • 2.20.4 Chiatai Tianqing Oxaliplatin Revenue, Gross Margin and Market Share (2020-2025)
    • 2.20.5 Chiatai Tianqing Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Oxaliplatin Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Oxaliplatin by Company Revenue
    • 3.2.2 Top 3 Oxaliplatin Players Market Share in 2024
    • 3.2.3 Top 6 Oxaliplatin Players Market Share in 2024
  • 3.3 Oxaliplatin Market: Overall Company Footprint Analysis
    • 3.3.1 Oxaliplatin Market: Region Footprint
    • 3.3.2 Oxaliplatin Market: Company Product Type Footprint
    • 3.3.3 Oxaliplatin Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Oxaliplatin Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Oxaliplatin Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Oxaliplatin Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Oxaliplatin Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Oxaliplatin Consumption Value by Type (2020-2031)
  • 6.2 North America Oxaliplatin Market Size by Application (2020-2031)
  • 6.3 North America Oxaliplatin Market Size by Country
    • 6.3.1 North America Oxaliplatin Consumption Value by Country (2020-2031)
    • 6.3.2 United States Oxaliplatin Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Oxaliplatin Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Oxaliplatin Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Oxaliplatin Consumption Value by Type (2020-2031)
  • 7.2 Europe Oxaliplatin Consumption Value by Application (2020-2031)
  • 7.3 Europe Oxaliplatin Market Size by Country
    • 7.3.1 Europe Oxaliplatin Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Oxaliplatin Market Size and Forecast (2020-2031)
    • 7.3.3 France Oxaliplatin Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Oxaliplatin Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Oxaliplatin Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Oxaliplatin Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Oxaliplatin Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Oxaliplatin Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Oxaliplatin Market Size by Region
    • 8.3.1 Asia-Pacific Oxaliplatin Consumption Value by Region (2020-2031)
    • 8.3.2 China Oxaliplatin Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Oxaliplatin Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Oxaliplatin Market Size and Forecast (2020-2031)
    • 8.3.5 India Oxaliplatin Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Oxaliplatin Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Oxaliplatin Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Oxaliplatin Consumption Value by Type (2020-2031)
  • 9.2 South America Oxaliplatin Consumption Value by Application (2020-2031)
  • 9.3 South America Oxaliplatin Market Size by Country
    • 9.3.1 South America Oxaliplatin Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Oxaliplatin Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Oxaliplatin Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Oxaliplatin Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Oxaliplatin Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Oxaliplatin Market Size by Country
    • 10.3.1 Middle East & Africa Oxaliplatin Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Oxaliplatin Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Oxaliplatin Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Oxaliplatin Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Oxaliplatin Market Drivers
  • 11.2 Oxaliplatin Market Restraints
  • 11.3 Oxaliplatin Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Oxaliplatin Industry Chain
  • 12.2 Oxaliplatin Upstream Analysis
  • 12.3 Oxaliplatin Midstream Analysis
  • 12.4 Oxaliplatin Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Oxaliplatin market size was valued at US$ 1094 million in 2024 and is forecast to a readjusted size of USD 1948 million by 2031 with a CAGR of 8.7% during review period.
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

    In this report, only the finished drug is covered, exclude API.
    Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.
    The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy"s laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.
    This report is a detailed and comprehensive analysis for global Oxaliplatin market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Oxaliplatin market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Oxaliplatin market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Oxaliplatin market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Oxaliplatin market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Oxaliplatin
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Oxaliplatin market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Oxaliplatin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Mannitol
    Glucose Solution
    Lactose Solution
    Others
    Market segment by Application
    Colorectal Cancer
    Stomach Cancer
    Ovarian Cancer
    Others
    Market segment by players, this report covers
    Sanofi-Aventis
    Yakult honsha
    Dr Reddy's laboratories
    Sun Pharmaceutical
    Teva
    Fresenius Kabi
    Hospira
    Mylan
    Jiangsu Hengrui Medicine
    Nanjing Pharmaceutical Factory
    Jiangsu Aosaikang Pharmaceutical
    Qilu Pharmaceutical
    Hisun Pharmaceutical
    Lunan Pharmaceutical
    Luoxin
    Halfsky Pharmacy
    YRPG
    Hainan Jinrui Pharmaceutical
    Jari Pharmaceutical
    Chiatai Tianqing
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Oxaliplatin product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Oxaliplatin, with revenue, gross margin, and global market share of Oxaliplatin from 2020 to 2025.
    Chapter 3, the Oxaliplatin competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oxaliplatin market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Oxaliplatin.
    Chapter 13, to describe Oxaliplatin research findings and conclusion.

    Buy now